AstraZeneca at Festival of Biologics 2026
Oct 13–15, 2026 Basel, Switzerland ~3k attendees Website
AstraZeneca takes part in 7 sessions at Festival of Biologics 2026 in Basel. Its sessions focus on the early steps of making antibody drugs: finding antibodies in single B cells, producing proteins, and testing cell lines at high throughput. A recurring thread is the use of AI and predictive models to design antibodies and judge how easy they will be to develop.
| Organization | Festival of Biologics 2026 Attendance |
|---|---|
AstraZeneca Cambridge, United Kingdom | |
Talk Tue Oct 13 16:50 Optimizing recombinant protein expression workflows by leveraging automation and predictive models Ways to speed up making proteins in the lab by combining automated workflows with models that predict the best genetic code choices. Talk Tue Oct 13 17:50 Advancing Antibody Discovery Through Integrated single B-Cell Technologies How to find therapeutic antibodies by profiling individual immune B cells, and how computer predictions are combined with the laboratory work. Talk Wed Oct 14 12:30 Chair Wed Oct 14 16:45 Talk Wed Oct 14 16:50 Integrating AI/ML into Biologics Discovery: Design, Optimization, Developability, and Immunogenicity How AI supports biologic drug discovery, from designing molecules to predicting how easily they are made and whether the body attacks them. Talk Thu Oct 15 12:20 Talk Thu Oct 15 12:20 |
Instantly find 20 buyers from AstraZeneca
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Terrapinn or the Festival of Biologics. Submit a correction